Stay updated on IMGN853 + Pembrolizumab in Endometrial Cancer Clinical Trial

Sign up to get notified when there's something new on the IMGN853 + Pembrolizumab in Endometrial Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the IMGN853 + Pembrolizumab in Endometrial Cancer Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    Added a government-operating-status notice and new version v3.2.0; removed old version v3.1.0.
    Difference
    3%
    Check dated 2025-10-06T05:29:47.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    The page update adds the new version tag v3.1.0 and removes the old v3.0.2 tag, signaling a software version upgrade.
    Difference
    0.1%
    Check dated 2025-09-29T03:05:32.000Z thumbnail image
  4. Check
    28 days ago
    No Change Detected
  5. Check
    36 days ago
    Change Detected
    Summary
    Updated revision from v3.0.1 to v3.0.2. Removed the 'Back to Top' element.
    Difference
    0.2%
    Check dated 2025-09-14T18:59:54.000Z thumbnail image
  6. Check
    43 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to 3.0.1, indicating a revision in the content. There are no significant changes to core content, names, pricing, or availability.
    Difference
    0.2%
    Check dated 2025-09-07T14:27:56.000Z thumbnail image
  7. Check
    50 days ago
    Change Detected
    Summary
    The web page has undergone significant changes, including the addition of a facility name and location, while key drug names such as Mirvetuximab Soravtansine and Pembrolizumab have been removed.
    Difference
    1%
    Check dated 2025-08-31T11:44:20.000Z thumbnail image
  8. Check
    64 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.11 to version 2.16.12.
    Difference
    0.1%
    Check dated 2025-08-17T01:40:44.000Z thumbnail image

Stay in the know with updates to IMGN853 + Pembrolizumab in Endometrial Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the IMGN853 + Pembrolizumab in Endometrial Cancer Clinical Trial page.